[VIVO] QoQ Quarter Result on 30-Sep-2016 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
29-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q4]
Profit Trend
QoQ- -37.27%
YoY- -35.15%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 50,140 54,125 46,809 46,998 50,665 51,259 47,160 4.17%
PBT 3,946 14,190 9,659 8,752 13,401 14,792 13,699 -56.41%
Tax 3,706 4,878 3,380 3,261 4,647 5,701 4,806 -15.92%
NP 240 9,312 6,279 5,491 8,754 9,091 8,893 -91.02%
Tax Rate -93.92% -34.38% -34.99% -37.26% -34.68% -38.54% -35.08% -
Total Cost 49,900 44,813 40,530 41,507 41,911 42,168 38,267 19.37%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.48 17.20 13.41 11.68 17.28 17.74 18.86 -91.36%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 0.01 0.22 0.15 0.13 0.21 0.22 0.21 -86.88%
EPS Diluted 0.01 0.22 0.15 0.13 0.21 0.21 0.21 -86.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.